OXFORD BIOMEDICA PLC (OXB.L)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. This filer's financial year end could not be read from its revenue history, so quarters are labelled by the calendar. Amounts in GBP.

Revenue Annual

0 60M 120M 180M 2024: 128.8M 2025: 168.7M 2024 2025

Gross Profit Annual

0 25M 50M 75M 2024: 53M 2025: 66M 2024 2025

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M 2024: -39.4M 2025: -22.5M 2024 2025

Net Income Annual

-60M -40M -20M 0 20M 40M 60M 2024: -48.6M 2025: -30.6M 2024 2025

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M 2024: -50.7M 2025: 507K 2024 2025

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M 2024: -58.2M 2025: -4.3M 2024 2025

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.